A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The main objectives of this study are to determine the feasibility and safety of AU-011 treatment of bladder cancer utilizing intratumoral injection with or without intramural injection and with or without laser application.
Epistemonikos ID: 7a8f6ee7f241123b45785b09ec0fafccb7e2d40f
First added on: May 13, 2024